Article

Nestle mulls Alcon sale

Nestlyy} SA might sell 25% ofAlcon if it decides to do a partial initial public offering of the unitnext year, according to CEO Peter Brabeck-Letmathe.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
Related Content
EssilorLuxottica set to acquire Optegra clinics
June 13th 2025

EssilorLuxottica set to acquire Optegra clinics

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

HIV drug lamivudine shows promise in treating diabetic macular edema
June 12th 2025

HIV drug lamivudine shows promise in treating diabetic macular edema

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Qlaris Bio announces development of QLS-111-FDC
June 12th 2025

Qlaris Bio announces development of QLS-111-FDC

Zeteo Biomedical secures US and EU patents for drug delivery technologies
June 12th 2025

Zeteo Biomedical secures US and EU patents for drug delivery technologies

© 2025 MJH Life Sciences

All rights reserved.